WHO WE ARE
As a family-held company, we are cognisant of how work shapes who we are and who we want to become. Our culture is enriched with a genuine ambition to make a mark, and together we strive to become individuals of remarkable value.
WHO WE ARE Aspiration & Values Leadership Our defining moments Sustainability Code of conduct Global presence
OUR FOCUS
We are a highly specialised company focused on carbohydrate chemistry and a global leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anaemia – a condition which more than 1 billion people live with, making it one of the largest global health challenges of our time.
OUR FOCUS Pharmaceuticals Carbohydrates Animal Health
PROGRAMMES
Discover our current research programme which highlight our commitment to groundbreaking studies and treatments, based on our expertise in iron metabolism.
PROGRAMMES Clinical Trials Petadeferitrin
CAREER
We are a fully integrated pharmaceutical company with many exciting opportunities ahead of us. Do you want to join us?
CAREER Job openings Life at Pharmacosmos
NEWS & MEDIA
We always strive to achieve new results and collaborations that can improve the quality of lives. Stay informed with our latest news and press releases.
NEWS & MEDIA News & Press Events Media
CONTACT US
We welcome all questions or inquiries. Get started by filling out a form or read about the way we are partnering.
CONTACT US Partnering with us Privacy policy

Home Who we are Leadership Thomas B. Riisager

Thomas B. Riisager

Advancing Pharmacosmos' Corporate Strategy: A Key Focus for Future Growth and Development.

Profile

Executive Vice President, Business Development & Strategy

A Key Focus for Future Growth and Development

Thomas Birger Riisager joined Pharmacosmos on 8 August 2024 as EVP of Business Development and Strategy. Thomas’ overall responsibilities include evaluation of in-organic growth opportunities including screening-, assessing- and execution of company- and product acquisitions and in- licensing opportunities. In addition, Thomas has the responsibility for further development of Pharmacosmos’ Corporate Strategy.

Prior to joining Pharmacosmos,

Thomas held similar positions as Chief Business Development Officer for UK based (Private Equity owned) Theramex and Barcelona based (family owned) Esteve. Prior to this Thomas spent 13 years at Lundbeck heading up Business Development & Strategy.

Aside from work,

Thomas enjoys biking, golfing and (watching) football.

Go to Leadership